Shared Care Protocols

 

The management of patients with some conditions can be complicated, and as a result it may not be possible to fully discharge patients from hospital back to the care of their General Practitioner (GP). Therefore, a system of Shared Care encompassing primary and hospital out-patient care is appropriate. You can access the list below for those medicines that have an agreed Shared Care Protocol within Cardiff and Vale UHB.


Shared care supporting documents:

 General Guidance      List of Shared Care Protocols                                                                                                                                      Consultant request letter to GP for shared care or near patient testing (NTP)                                                                        Letter to GP – to confirm patient is stable on shared care drug      Shared Care Incident Report Form 

(Access the list of Shared Care Protocols below )

The following Shared Care Protocols are organised by generic drug name.


Protocol Number Drug

Indication

CV44 Amiodarone Severe cardiac rhythm disorders
CV02 Apomorphine Disabling Motor Fluctuations in Parkinson’s Disease
CV46 Atomoxetine Attention Deficit Hyperactivity Disorder (ADHD), Hyperkinetic Disorder (HKD) in children 6 years and older, adolescents and adults
CV51 Azathioprine Auto-immune conditions, usually when corticosteroid therapy alone provides inadequate control
CV04 Azathioprine Liver transplantation in adults
CV26 Ciclosporin Severe psoriasis
CV29 Ciclosporin (Neoral) Rheumatoid arthritis
CV56 Dalteparin Treatment of venous thromboembolism in patients with solid tumours
CV20 Disulfiram Maintenance of abstinence in alcohol dependence
CV38 Dornase alfa Cystic fibrosis
CV08 Erythropoietin Anaemia associated with chronic renal failure in children
CV10 Ketamine Pain in a palliative care setting not responding to opioids and adjuvant therapy
CV40 Lanreotide (Somatuline Autogel) Acromegaly, carcinoid Syndrome and other peptide hormone secreting tumours
CV11 Leflunomide Rheumatoid arthritis and psoriatic arthritis
CV22 Leuprorelin Precocious puberty in children
CV57 Lisdexamfetamine Attention deficit hyperactivity disorder (ADHD) in children aged 6 years of age and over
CV12 Lithium Prophylaxis of mania, bipolar disorder, recurrent depression
CV25 6MP ( 6-Mercaptopurine) Inflammatory Bowel Disease
CV54 Melatonin For children and adolescents (up to and including 18 years) with significant sleep onset difficulties
CV14 Methadone Pain requiring methadone for control
CV55 Methotrexate Rheumatoid arthritis and various auto-immune conditions, usually when corticosteroid therapy alone provides inadequate control
CV42 Methylphenidate Attention Deficit Hyperactivity Disorder (ADHD), Hyperkinetic Disorder (HKD)
CV53 Mycophenolate mofetil Various conditions, which characteristically respond to immunosuppressive therapy
CV16 Octreotide (Sandostatin) Palliative care setting
CV33 Octreotide LAR (Sandostatin LAR) Acromegaly, Carcinoid Syndrome and other peptide hormone secreting tumours
CV17 Penicillamine Rheumatoid arthritis
CV39 Riluzole Amyotrophic Lateral Sclerosis (ALS)
CV19 Sodium aurothiomalate (Myocrisin) Rheumatoid arthritis
CV34 Somatropin Adult growth disorders
CV27 Somatropin Growth Hormone in children
CV41 Sulfasalazine Inflammatory Bowel Disease (Crohn’s and ulcerative colitis)
CV21 Sulfasalazine Rheumatoid arthritis
CV43 Tacrolimus Liver transplantation in adults
CV48 Tobramycin Chronic colonisation with pseudomonas aeruginosa in cystic fibrosis
CV23 Triptorelin Precocious puberty in children